High Z Semiconductor Gamma-Ray Detector for Nuclear Non-Proliferation

Award Information
Agency: Department of Energy
Branch: N/A
Contract: DE-FG02-11ER90081
Agency Tracking Number: 97534
Amount: $149,999.00
Phase: Phase I
Program: SBIR
Awards Year: 2011
Solitcitation Year: 2011
Solitcitation Topic Code: 51 b
Solitcitation Number: DE-FOA-0000413
Small Business Information
Radiation Monitoring Devices, Inc.
MA, Watertown, MA, 02472-4699
Duns: 073804411
Hubzone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Leonard Cirignano
 Mr.
 (617) 668-6800
 lcirignano@rmdinc.com
Business Contact
 Gerald Entine
Title: Dr.
Phone: (617) 668-6800
Email: gentine@rmdinc.com
Research Institution
 Stub
Abstract
There is a critical need for low cost, high performance gamma-ray detectors for identification and localization of special nuclear materials (SNM) such as plutonium and weapons grade uranium. Cadmium zinc telluride (Cd1-xZnxTe or & quot;CZT & quot;) has emerged as the leading room temperature semiconductor gamma ray detector. However, despite decades of research and recent improvements in crystal growth and processing techniques, the yield of device grade CZT is low. To meet the needs of homeland security a lower cost alternative to CZT is desirable. In the search for semiconductors that have potential for higher intrinsic detection efficiency than CZT and potentially lower cost, lead-containing chalcogenides have been identified as promising candidates. These materials have several favorable properties for room temperature gamma-ray detection including high Z (due to Pb), wide band gap (1.6 eV to 2.8 eV range) and can exhibit high electron mobility and no ionic conductivity. The goal of the proposed project is to investigate growth of high quality crystals of PbGa2Se4 and then implement advanced detector designs based on such detectors. Commercial Applications and Other Benefits: In addition to nuclear non-proliferation, nuclear medicine, computed tomography and non-destructive testing are other applications where high performance, less expensive spectrometers will have beneficial applications. One medical application that RMD already takes part in is the production of surgical probes used for localizing radiopharmaceutical uptake. These tools have become part of a technique (sentinel node biopsy) that minimizes the debilitating nature of removing lymph nodes in monitoring the spread of breast cancer. As this technique has become more accepted for breast cancer, other treatment areas have been considered such as monitoring PET isotopes (emitting at 511 keV) which have greater specificity to cancer sites. A high energy emission presents a challenging probe design because of scattering and lack of efficiency. New large PbGa2Se4 detectors capable of scatter rejection would be a very welcome solution if available

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government